ロード中...
Cancer neoantigens and immunogenicity: mutation position matters
Cancer mutations can elicit protective immunity. Computational methods are critical for selecting these neoantigens for immunotherapy. While significant progress has been made in the field in predicting peptide presentation, our understanding of which mutated peptide is recognized as foreign by T ce...
保存先:
| 出版年: | Mol Cell Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7199756/ https://ncbi.nlm.nih.gov/pubmed/32391432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2020.1740071 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|